news

08/04/08
Electro-Optical Sciences Completes Patient Accrual in MelaFind(R) Pivotal Trial for Early Melanoma Detection

07/31/08
Electro-Optical Sciences Announces $11.8 Million Registered Direct Offering

 



07/01/08
Electro-Optical Sciences Joins Russell Microcap Index
about about About EOS

 Electro-Optical Sciences (EOS) is a medical device company focused on the design and development of a non-invasive, point-of-care instrument to help physicians more effectively diagnose melanoma at an early stage.
MelaFind®, the company's flagship product, incorporates advanced imaging technology and algorithms to provide physicians with unique data and an immediate recommendation of whether a suspicious lesion should be biopsied.
The MelaFind® Solution
 
To date, MelaFind® has been studied on approximately 6,000 skin lesions from approximately 4,500 patients at over 30 clinics. Our clinical studies have demonstrated that MelaFind® missed fewer melanomas and produced fewer false positives than the skin cancer specialists who participated in the studies. Read more...

Melanoma Problem

Cancers of the skin have a higher incidence than all other cancers combined with over 120,000 new cases of melanoma estimated in 2007 and a similar number of new cases projected in 2008. Incidence rates continue to rise dramatically. Read more...


MelaFind is a registered trademark of Electro-Optical Sciences Inc.

Copyright 2006, Electro-Optical Sciences, Inc.